- Udyam number
- UDYAM-GJ-01-0027656

About Espee Therapeutics LLP
Data last updated:
Espee Therapeutics LLP is a limited liability partnership (LLP) based in Ahmedabad, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 25 November 2016 and has been in existence for over 10 years.
Its director Swapnil Jatin Shah is #1,233 among India's richest people (2026).
The LLP is registered with the Registrar of Companies (ROC), Ahmedabad, under LLPIN AAH-8938. Its GSTIN is 24AAGFE1071K1ZM (Gujarat).
The LLP has a total obligation of contribution of ₹1 Cr. It is led by designated partners Swapnil Jatinbhai Shah and Anar Swapnil Shah.
Its latest statement of accounts is for the year ended 31 March 2025. The registered office is at Jayantilal Park, Ahmedabad, Gujarat.
As per the financials filed for FY 2021, the LLP reported a revenue of ₹13.65 Cr, a growth of 80% compared to the previous year. For the same year it recorded a net profit of ₹3.78 Cr (net margin 27.7%) and EBITDA of ₹13.99 Cr (EBITDA margin 102.4%). Revenue has grown at a compounded annual rate (CAGR) of 57% over three years.
The LLP has about 21 employees on its provident fund (EPFO) records.
As per MCA filings, the LLP has open charges of ₹1.07 Cr and satisfied charges of ₹10.24 Cr on record. Court records list 1 case involving the LLP, including 1 filed against it.
Espee Therapeutics LLP is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-GJ-01-0027656). For more details, the LLP can be reached via its website espeelife.com.
Company details
Recognitions & Rankings of Espee Therapeutics
- #1,233 Swapnil Jatin Shah ₹1,900 Cr
Contact details
Espee Therapeutics LLP's registered office is in Ahmedabad, Gujarat. Its website is espeelife.com. Its e-mail address is in the company report.
- Email
- Website
- Registered AddressS.T. 1101 One 42 B/H. Ashok Vatika Nr. Jayantilal Park Brts Ambli Bopal Ro, Ad, Ahmedabad, Gujarat, India – 380054
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Espee Therapeutics LLP, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Espee Therapeutics LLP
FY 2025 filings availableEspee Therapeutics LLP reported revenue of ₹13.65 Cr (up 80% YoY) for FY 2021.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 57% over three years, including 80% growth in the latest year. EBITDA rose 95% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Statement of Account and Solvency | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|---|
| Income and Expenditure | |||||
| Turnover | ₹13.65 Cr | ||||
| Other Income | |||||
| Total Income | |||||
| Purchases and Direct Costs | |||||
| Personnel Expenses | |||||
| Administrative Expenses | |||||
| Interest | |||||
| Depreciation | |||||
| Total Expenses | |||||
| Profit Before Tax | |||||
| Tax | |||||
| Profit After Tax | ₹3.78 Cr | ||||
| Profit Transferred to Partners | |||||
| Assets and Liabilities | |||||
| Partners' Contribution | |||||
| Reserves and Surplus | |||||
| Secured Loans | |||||
| Unsecured Loans | |||||
| Trade Payables | |||||
| Other Liabilities and Provisions | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Loans and Advances | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Statement of Account and Solvency | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|---|
| Profitability | |||||
| Net Profit Margin | 27.7% | ||||
| Return on Partners' Funds | |||||
| Return on Assets | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Debt to Partners' Funds | |||||
| Interest Coverage | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Turnover Growth | |||||
| Profit Growth | |||||
To see the full financial statements and ratios of Espee Therapeutics LLP, buy the company report.
Designated partners of Espee Therapeutics LLP
Espee Therapeutics has 2 designated partners on record. No former designated partners are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Swapnil Jatinbhai Shah Also directs: Aelius Projects LLP, Remus Pharmaceuticals Limited, Senores Pharmaceuticals Limited and 4 more | Designated Partner | 25 Nov 2016 | 9 Years 11 Months | Current |
| Anar Swapnil Shah Also directs: Aelius Projects LLP, Remus Pharmaceuticals Limited, Senores Biologics Private Limited and 5 more | Designated Partner | 25 Nov 2016 | 9 Years 11 Months | Current |
Auditor
Espee Therapeutics LLP is audited by PARIKH & MAJMUDAR for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| PARIKH & MAJMUDAR | FY 2021 | 107525W |
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 26 Nov 2025 | 101191230 | Hdfc Bank Limited | ₹32.08 Lakh | Open | |
| 06 May 2024 | 100927643 | Hdfc Bank Limited | ₹20 Lakh | Open | |
| 16 Nov 2023 | 100818907 | Hdfc Bank Limited | ₹55 Lakh | Open | |
| 05 Apr 2023 | 100710513 | Icici Bank Limited | ₹2.45 Cr | Satisfied | |
| 15 Jan 2021 | 100429089 | Icici Bank Limited | ₹7.79 Cr | Satisfied |
To see the full charge records of Espee Therapeutics LLP, buy the company report.
Total charge records: 5 View all charges
Legal cases
Espee Therapeutics LLP has 1 court case on record: 1 filed against it. All case is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Ahmedabad, Gujarat | Criminal complaint | Filed against the company by Government of Gujarat | Disposed |
To see the full case history of Espee Therapeutics LLP, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Espee Therapeutics LLP; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Espee Therapeutics LLP has a workforce of 21 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 21 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 |
To see the full employee and EPFO history of Espee Therapeutics LLP, buy the company report.
GST
Espee Therapeutics has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAGFE1071K1ZM | Gujarat | Active | 12 Jul 2017 |
To see the full GST registrations and return filing status of Espee Therapeutics LLP, buy the company report.
Recent activity
Espee Therapeutics LLP has 2 designated partner changes on record since 2016: 2 appointments. The latest: Anar Swapnil Shah was appointed as Designated Partner on 25 Nov 2016.
1 earlier event is in the company report.
Frequently asked questions
Espee Therapeutics is an active limited liability partnership based in Ahmedabad, Gujarat, India. The LLP works in drug formulation and development, within the pharma industry. It was incorporated on 25 November 2016 (10+ years old) and is registered under LLPIN AAH-8938.
Espee Therapeutics has 2 current designated partners:
- Swapnil Jatinbhai Shah - Designated Partner
- Anar Swapnil Shah - Designated Partner
The latest financial statements of Espee Therapeutics on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 31 March 2025. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Espee Therapeutics is 24AAGFE1071K1ZM, registered in Gujarat.
The LLPIN (Limited Liability Partnership Identification Number) of Espee Therapeutics is AAH-8938. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.
Espee Therapeutics has 1 court case on record: 1 filed against it.
Espee Therapeutics was incorporated on 25 November 2016, making it 10+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Anar Swapnil Shah was appointed as Designated Partner on 25 Nov 2016. Swapnil Jatinbhai Shah was appointed as Designated Partner on 25 Nov 2016.
Yes, Espee Therapeutics is registered as an MSME under Udyam registration (number: UDYAM-GJ-01-0027656).
Espee Therapeutics can be reached through the website espeelife.com. Its registered office is in Ahmedabad, Gujarat, India.

